Please click here to check who's online and chat with them.

Find Verified Sd Biosensor Standard M Ncov Rt Detection Kit Suppliers, Manufacturers and Wholesalers

Apr-15-20
 
STANDARD M nCoV Real-Time Detection kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples.

- One tube reaction for identification and detection of 2019-nCoV
- One-step Real-Time RT-PCR
- Provide all reagents required for PCR
- Designed according to WHO interim guidance for laboratory testing for 2019 novel coronavirus (2019-nCoV) in humans"
- nCoV primers/probes ORF1ab (RdRp) gene, E gene
- Provide Internal controls

- Test time : 90mins
- Specimen : Nasopharyngeal swab, Oropharyngeal swab, Sputum
- Applicable machine : CFX96. ABI7500
- CE, FDA EUA
Jun-25-22
 
Cat No : 11NCo10. SD biosensor STANDARD M nCoV Real-Time Detection kit is used for identification and detectionof novel coronavirus (2019-nCoV) ORF1ab (RdRp) gene and E gene in humannasopharyngeal swab, oropharyngeal swab, and sputum specimens using reversetranscription (RT) real-time PCR. This kit is helpful for the auxiliary diagnosis of 2019novel coronavirus disease (COVID-19). The test results are for clinical referenceonly and cannot be used as a basis for confirming or excluding cases alone.
GOLD Member
Jan-05-22

New Omicron Covid Test Kit

$9
MOQ: 1300000  
Sample Available
 
Application
Suspected case test in epidemic area
Early test of fever clinic and CDC
Screening of primary medical institutions
Inspection of floating population in public areas
Performance Characterisitics
Sample tyep: nasal swab Time to result: 15-20 minutes
Sensitivity: 97.70% Specificity: 99.84% Accuracy:98.97%
Layperson study statistics
99.84% of non-professionals carried out the test without requiring assistance
99.82% of different types of results were interpreted correctly.

Parameters:
A Short Test Time: 15 mintues
B Accuracy: More than 98.1%
C Sensitivity: 96.4% Specificity: 100%
D Easy operation: Nasal Swab
E One Step solution
F Lower cost with high efficiency
G Package: 1 Test/Kit, 5 Tests/Kit, 25 Tests/Kit
H It can detection for Omicron Virus

Price and Minumum Quantity
Price FOB in USD: 1.5Minimum Order Qty: 500000 Pieces
Production Capacity: 100 Million Boxes Per WeekPackaging: 1,5,20,25,40,100,200 Pcs Per Box
Sample: Available. Sample Cost Born By Buyer
Product Model And Origin
Brand: jwfModel: jwf01
Seller Code: Jwf
Standards: Ce
Competitive Advantages
Lower cost with high efficiency
Detection for omicron virus
Easy operation
Short test time
Other Details
Omicron covid test kit
Covid test kit
Omicron test card
Covid test card
GOLD Member
Jan-05-22
 
Angiten-COVID-19 Virus Test Kit (Colloidal Gold)
Quantity of box: 25 persons/box
Brand: Easysweet
NMPA (National Medical Products Administration): Approved
CE: with CE mark
BfArM: listed
Test Method: Antigen Test
Result Time: 10-15 mins
Sample Type: Nasal Swab
Sensitivity: 96.70%
Specificity: 100%
Accuracy: 98.94%
Shelf Life: 24 months
Storage Temperature: 2-30 Degree Celsius
Country of Origin: Made in China
Additional Information:
Production Capacity: 1 million
Delivery Time: 10-15 days
Packaging Details: 25 tests in a pack, 40packs/ carton
Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only.

Price and Minumum Quantity
Price FOB in USD: NegotiableMinimum Order Qty: 10000
Production Capacity: 1000000Packaging: 25 Persons/box
Sample: Available. Sample Cost Born By Buyer
Product Model And Origin
Brand: Easysweet
HS Code: 3822009020
Standards: Ce
Competitive Advantages
Best price with shortest delivery time
Best price with shortest delivery time
Best price with shortest delivery time
Best price with shortest delivery time
Other Details
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
GOLD Member
VERIFIED
Jun-29-21
Supplier From Faridabad, Haryana, India
 
Steel billets result from the second stage of the steel production process. They are hot-rolled or forged from an ingot or strand cast.

steel billets from 45 x 45 mm to 150x150 mm, and round steel billets from 120 mm to 270 mm in diameter. Length : Specifiable up to 12 m Quality : In various internationally well known standards including afnor (nf), aisi, astm, bs, din, euronorm, gost, jis, iso, sae, si, ts, uni, etc. (eg. Astm a 615 gr 40 or 60, bst 420 s, din 488, st 37.2 din 17100, nfa 35015 and 16, bs 4449 (gr 250 or 460), jis g 3112 (sd 30, 35, 40), si 739 s 400, si 739 s 400 w, feb 44 k, 3 sp/ps or 5 sp/ps gost 380 88, 35 gs or 25 g2s, gost 5781-82, etc) Other grades available according to customer's request
774 Sd Biosensor Standard M Ncov Rt Detection Kit Suppliers
Short on time? Let Sd Biosensor Standard M Ncov Rt Detection Kit sellers contact you.
VERIFIED
Jul-14-21
Supplier From Dubai, Dubai, United Arab Emirates
 
RT PCR-Detection Kit
VERIFIED
Feb-16-22
 
Sample Types :
Including Nasopharyngeal swab, Oropharyngeal swab, Sputum

Controls :
Internal control, UNG enzyme and dUTP used to reduce risk of contamination, false positive and false negative results

Product Information

Upper and lower respiratory specimens such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate.

Authorized Laboratories
Laboratories certified under the Clinical Laboratory Improvement Amendments
of 1988 (CLIA), 42 U.S.C. 263a, to perform high complexity tests.

About Emergency Use Authorization
(EUA)
This test (1) has not been FDA cleared or approved, (2) has been authorized by
FDA under an EUA for use by authorized laboratories, (3) has been authorized
only for the detection of nucleic acid from SARS-CoV-2, not for any other
viruses or pathogens, and (4) is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C.360bbb-3(b)(1), unless the authorization
is terminated or revoked sooner.
VERIFIED
Feb-16-22
 
The COVID-19 RT-PCR Detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal
aspirate) from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, 42 U.S.C.
263a, to perform high complexity tests.
Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infective status. The agent detected may not be
the definite cause of disease. Positive results do not rule out bacterial co-infection with other viruses.
Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities.
Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.
The COVID-19 RT-PCR Detection Kit is intended for use by qualified trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures. The COVID-19 RT-PCR Detection Kit is only for use under the Food and Drug Administration's Emergency Use Authorization.

PRINCIPLE OF DETECTION
This product is a fluorescent probe-based Taqman RT-PCR assay system. Firstly, the RNA of SARS-CoV-2 will be reverse transcribed into cDNA by reverse transcriptase, and then PCR amplification will be performed with cDNA as template. During amplification of the template, the TaqMan probe will
be degraded due to the 5'-3 polymerase activity and exonuclease activity of Taq DNA polymerase, then the separation of fluorescent reporter and quencher enables the fluorescent signal to be detected by instrument. The ORF1ab gene of SARS-CoV-2 will be detected qualitatively by FAM channel, the N
gene of SARS-CoV-2 will be detected qualitatively by JOE channel, the E gene of SARS-CoV-2 will be detected qualitatively by ROX channel, and the internal reference will be detected by CY5 channel.
dUTP and UNG enzyme are used in the kit to prevent contamination of the amplified products.
Internal reference is used in the kit for quality control starting from sample collection
VERIFIED
Feb-16-22
 
Indication: Qualitative detection of nucleic acid from SARS-CoV-2 in upper
and lower respiratory specimens (such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19 by their healthcare provider.
Emergency use of this test is limited to authorized laboratories.
Authorized Laboratories: Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, to perform high
complexity tests.

This letter is in response to your1 request that the Food and Drug Administration (FDA) issue an Emergency Use Authorization (EUA) for emergency use of your product,2 pursuant to Section 564 of the Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. 360bbb-3). On February 4, 2020, pursuant to Section 564(b)(1)(C) of the Act, the Secretary of the
Department of Health and Human Services (HHS) determined that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19.
Pursuant to Section 564 of the Act, and on the basis of such determination, the Secretary of HHS then declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 subject to the terms of any authorization issued under Section 564(a) of the Act.

Having concluded that the criteria for issuance of this authorization under Section 564(c) of the Act are met, I am authorizing the emergency use of your product, described in the Scope of Authorization of this letter (Section II), subject to the terms of this authorization.
I. Criteria for Issuance of Authorization I have concluded that the emergency use of your product meets the criteria for issuance of an authorization under Section 564(c) of the Act, because I have concluded that:
1. The SARS-CoV-2 can cause a serious or life-threatening disease or condition,
including severe respiratory illness, to humans infected by this virus;
2. Based on the totality of scientific evidence available to FDA, it is reasonable to believe that your product may be effective in diagnosing COVID-19, and that the known and potential benefits of your product when used for diagnosing COVID-19, outweigh the known and potential risks of your product; and, 3. There is no adequate, approved, and available alternative to the emergency use of your
product.
4
II. Scope of Authorization
I have concluded, pursuant to Section 564(d)(1) of the Act, that the scope of this authorization is limited to the indication above.
VERIFIED
Feb-16-22
 
Commodity: Covid-19 RT-PCR Detection Kit
Spec.96 tests/kit
Price:FOB SHANGHAI USD3.30/test, USD316.8/kit
$3.60/TEST CIF NY AIRPORT OR OTHER MAJOR AIRPORTS USA OR EUROPE OR S. AMERICA OR MIDDLE EAST
Payment: T/T ADVANCE 50% BALANCE BEFORE DEPARTURE OR Sight Irrevocable TRANSFERABLE LC Delivery: By AIR, 50days after receipt and confirmation of LC
May-05-23
 
Specification: 50T/kit or 100T/kit vial; 48T/kit or 96T/kit 0.1mL 8 strips/0.2mL 8 strips.
Canine distemper virus(CDV) is caused by a single-stranded RNA virus of the family . The disease is highly contagious via inhalation. The distemper virus real time PCR detection kit is intended for the qualitative detection of Canine distemper virus in samples by using real time PCR systems.
Jun-22-21

Real Time Rt-Pcr Detection Kit

$3 - $4
MOQ: Not Specified
Supplier From Guangzhou, Guangdong, Singapore
 
This kit is intended for qualiativein vitro detection of Orf1ab and N genes of Novel Coronavirus 2019-nCoV which are found in throat swab,sputum and alveolar lavage fuid samples of suspected cases of pneumonia,suspected cases of clustering and other patients who need to carry out diagnosis or differential diagnosis of Novel Coronavirus 2019-nCoV infection.
Nov-11-21
 
25 tests per box
Nov-11-21
 
Lowest detection line:200 copy/ml
CE marks
Apr-15-20
 
SolGent DiaPlexQâ?¢ Novel Coronavirus (2019-nCoV) Detection Kit CE-IVD

Real-Time OneStep RT-PCR based assay system for detection of 2019-nCoV
CE-IVD

DiaPlexQâ?¢ Novel Coronavirus(2019-nCoV) Detection Kit is CE-IVD reagent. It is screening kit to detect Novel Corona Virus as 2019-nCoV from isolated total RNA. Basic principal of this kit is Real-time PCR method, which is able to detect specific target gene into total RNA. One step RT-PCR contents are progressively apply for one tube RT(Reverse Transcription) reaction and PCR amplification. You can monitoring the nucleic acid amplification result based on real time condition through the amplification plot. The Control Template (2019-nCoV) is provide as positive control to assist the clinical sample data comparison analysis.

- Detection target : 2019-nCoV ( COVID-19 )
- Target region : Orf1a, N gene
- Detection technology : Real-Time OneStep RT-qPCR
- Specimen type : Nasopharyngeal swab, Oropharyngeal swab, Sputum
- Compatible instruments : CFX96â?¢ Real-Time PCR System (Bio-Rad), ABI 7500 / 7500 Fast Real-Time PCR System (Applied Biosystems)
- PCR running time : ~ 120 mins

- Simple & Rapid detection system: OneStep Multiplex RT-qPCR based detection
- HotStart PCR: high-specificity
- Reliable system: automatic PCR control (not Internal control)
- Easy-to-use master mix: just adding template and Primer/Probe Mix
- Positive control included (Plasmid)
May-05-23
 
RT-PCR direct Detection Kit is intended to be used to achieve direct detection of Severe acute respiratory syndrome coronavirus 2 viral RNA from nasal swabs, nasopharyngeal swabs and oropharyngeal swabs from patients with signs and symptoms of infection who are suspected of COVID-19. This product provides dual-detections of two independent genes of a single tube. gene and N gene is amplified and detected in FAM and HEX channel, respectively. An internal control is set with a Cy5 labeled probe using the RNase P gene of human as the target, to monitor the amplification effect of the detection system.
Our nucleic acid detection reagent can be transported at room temperature by freeze-drying technology, and can be stored at low temperature for a long time for one and a half years, and maintain good effectiveness.
Apr-29-22
 
Multiplex One Step RT-qPCR Probe Kit is a multiplex quantitative PCR kit based on RNA as template. In the process of the experiment, reverse transcription and quantitative PCR were carried out in the same tube, which simplified the experimental operation and reduced the risk of contamination.

In this kit, the first strand cDNA was efficiently synthesized by heat-resistant Hifair V reverse transcriptase and quantitatively amplified by UNICON HotStart Taq DNA polymerase. The kit mainly contains optimized MP buffer, enzymes mix, etc. The buffer solution already contains Mg2+ and dNTP. In addition, the factors that can effectively inhibit the non-specific PCR amplification and improve the amplification efficiency of multiple qPCR reactions are added, which can ensure the amplification efficiency and carry out up to four reactions.

Quantity: 100 T, 1000 T, 10000 T
Applications: RT-qPCR, 4-plex reaction
Sample Type: RNA template
main enzyme: Hifair V Reverse Transcriptase,UNICON HotStart Taq DNA Polymerase
Category: IVD PCR
Research Area: RT-qPCR
Apr-26-20
Supplier From Daegu, Daegu, South Korea (Republic Of Korea)
 
Type: TR-PCR
One kit can be used for 96 times.
Accuracy: 95%.
Storage: minus 15 degree - minus 25 degree
Packing condition is dry ice in side of packing
Expiration date: 12 months
Mar-17-21
 
PERFORMANCE SPECIFICATIONS
1. Detection limitation: 200 copies /mL.
2. Precision: using precision reference CV1 and CV2 for within-batch and
between-batch detection, the coefficient of variation (CV) of their Ct values
is â?¤ 5.0%.
3. Conformity rate of Negative Control: 100%
4. Conformity rate of Positive Control: 100%
5. Specificity: This product will not cross react with positive samples of
human coronavirus HKU1 OC43, NL63 and 229E, SARS coronavirus, MERS
corona-virus, H1N1 (new influenza A (H1N1) virus (2009), the seasonal
H1N1) and H3N2, H5N1, H7N9, influenza B Yamagata, Victoria, respiratory
syncytial virus type A, B, parainfluenza type 1, 2, 3, rhinovirus species A, B
and C, adenovirus, 1, 2, 3, 4, 5, 7 and 55, enterovirus species A, B, C,
D,Human pulmonary virus, partial pulmonary virus, EB virus, measles virus,
human cytomegalo virus, rotavirus, norovirus, mumps virus, varicella-zoster
virus and mycoplasma pneumoniae, chlamydia pneumoniae, legionella,
bordetella pertussis, haemophilus influenzae, staphylococcus aureus,
streptococcus pneumoniae, pyogenic streptococcus, klebsiella pneumoniae,
mycobacterium tuberculosis, pyogenic streptococcus, candida albicans,
candida glabrata, newborn Cryptococcus and human genome DNA.
Sep-14-20
 
USD$18.00

AccuPowe COVID-19 Real-Time RT-PCR Kit is an in vitro diagnostic kit that helps diagnose COVID-19 infections, detects SARS-CoV-2 (E gene and RdRp gene) RNA from a suspected infection patient's sample (such as sputum, nasopharyngeal swab, oropharyngeal swab) through Real-Time Polymerase chain reaction(PCR) using ExiStation Universal MDx system.

Validated to:
Bio-Rad CFX96
ABI 7500 Fast

Target Genes: Rdrp, E
774 Sd Biosensor Standard M Ncov Rt Detection Kit Suppliers
Short on time? Let Sd Biosensor Standard M Ncov Rt Detection Kit sellers contact you.
Explore Sd Biosensor Standard M Ncov Rt Detection Kit related import export discussions